Events

Yesterday, we were honored to be invited to the Investor Conference for Performance Presentation hosted by the Taipei Exchange (櫃買中心之櫃買市場業績發表會). We shared our company profile, industry outlook, and the latest R&D progress with investors and partners.

▶ Corporate Presentation Link：https://www.geherbs.com/show/show-1692409.htm

◆ Core Strengths of G&E Herbal Biotechnology

◎ Global Exclusive Patent — SR-100®｜Advancing the Future of Botanical Drug Development with International Patents & Clinical Evidence

SR-100® has obtained invention patents in multiple countries, including the United States, Japan, Korea, Germany, New Zealand, and Australia. Its innovative technology and proven safety have received numerous awards and recognition from governmental authorities, demonstrating strong potential for international clinical applications.

Research on the SR-100® active ingredient has been clinically validated and published in leading international dermatology journals.

▶ SR-100® Publication Link: https://lurl.cc/bZxuF3

◎ Hepanamin® ｜A Breakthrough in Oral Absorption

The silymarin dissolution rate meets the high-standard absorption specifications of both the United States Pharmacopeia (USP) and the Taiwan Chinese Pharmacopoeia (T.C.P.).

G&E Herbal Biotechnology operates fully certified PIC/S GMP pharmaceutical, food, and skincare manufacturing facilities. We focus on OBM and customized collaborations through a diversified business model.

From botanical extraction to finished products, the entire production process is completed in-house through our laboratories and GMP facilities—ensuring stable quality, safety, and reliability.

＊Advancing Botanical New Drugs & Clinical Research

SR-T100® Injection: Developed for the treatment of malignant ascites in cancer patients; clinical trials are actively progressing.

The SR-T100® active ingredient has demonstrated efficacy in delaying skin aging, reducing fine lines, and improving skin firmness and radiance.

It has completed Phase II and Phase III clinical trials for skin cancer and condyloma acuminatum, with findings published in internationally recognized medical journals.

Its clinical value has garnered significant global attention and acclaim.